These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26010568)
1. Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia. Mantelli M; Avanzini MA; Rosti V; Ingo DM; Conforti A; Novara F; Arrigo G; Boni M; Zappatore R; Lenta E; Moretta A; Acquafredda G; de Silvestri A; Cirillo V; Cicchetti E; Algeri M; Strocchio L; Vinti L; Starc N; Biagini S; Sirleto P; Bernasconi P; Zuffardi O; Maserati E; Maccario R; Zecca M; Locatelli F; Bernardo ME Br J Haematol; 2015 Sep; 170(6):826-36. PubMed ID: 26010568 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients. Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808 [TBL] [Abstract][Full Text] [Related]
3. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552 [TBL] [Abstract][Full Text] [Related]
4. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production. Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345 [TBL] [Abstract][Full Text] [Related]
5. Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia. Conforti A; Biagini S; Del Bufalo F; Sirleto P; Angioni A; Starc N; Li Pira G; Moretta F; Proia A; Contoli B; Genovese S; Ciardi C; Avanzini MA; Rosti V; Lo-Coco F; Locatelli F; Bernardo ME PLoS One; 2013; 8(11):e76989. PubMed ID: 24244271 [TBL] [Abstract][Full Text] [Related]
6. Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient. Conforti A; Taranta A; Biagini S; Starc N; Pitisci A; Bellomo F; Cirillo V; Locatelli F; Bernardo ME; Emma F J Transl Med; 2015 May; 13():143. PubMed ID: 25947233 [TBL] [Abstract][Full Text] [Related]
7. Characterization of bone marrow mesenchymal stromal cells in aplastic anaemia. Hamzic E; Whiting K; Gordon Smith E; Pettengell R Br J Haematol; 2015 Jun; 169(6):804-13. PubMed ID: 25819548 [TBL] [Abstract][Full Text] [Related]
8. Role of the mesenchymal stromal cells in bone marrow failure of Fanconi Anemia patients. Zubicaray J; Ivanova M; Iriondo J; García Martínez J; Muñoz-Viana R; Abad L; García-García L; González de Pablo J; Gálvez E; Sebastián E; Ramírez M; Madero L; Díaz MÁ; González-Murillo Á; Sevilla J Front Cell Dev Biol; 2024; 12():1286815. PubMed ID: 39119037 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats. Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow. Hofer EL; Labovsky V; La Russa V; Vallone VF; Honegger AE; Belloc CG; Wen HC; Bordenave RH; Bullorsky EO; Feldman L; Chasseing NA Stem Cells Dev; 2010 Mar; 19(3):359-70. PubMed ID: 19388812 [TBL] [Abstract][Full Text] [Related]
11. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096 [TBL] [Abstract][Full Text] [Related]
12. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells. Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160 [TBL] [Abstract][Full Text] [Related]
13. Genomic alterations in human umbilical cord-derived mesenchymal stromal cells call for stringent quality control before any possible therapeutic approach. Borghesi A; Avanzini MA; Novara F; Mantelli M; Lenta E; Achille V; Cerbo RM; Tzialla C; Longo S; De Silvestri A; Zimmermann LJ; Manzoni P; Zecca M; Spinillo A; Maccario R; Zuffardi O; Stronati M Cytotherapy; 2013 Nov; 15(11):1362-73. PubMed ID: 24094488 [TBL] [Abstract][Full Text] [Related]
14. Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplant. Ding L; Zhu H; Yang Y; Wang ZD; Zheng XL; Yan HM; Dong L; Zhang HH; Han DM; Xue M; Liu J; Zhu L; Guo ZK; Wang HX Leuk Lymphoma; 2014 Jul; 55(7):1635-44. PubMed ID: 24180332 [TBL] [Abstract][Full Text] [Related]
15. Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells. Xu J; Li X; Cole A; Sherman Z; Du W Stem Cells; 2018 May; 36(5):785-795. PubMed ID: 29377497 [TBL] [Abstract][Full Text] [Related]
16. Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency. Starc N; Ingo D; Conforti A; Rossella V; Tomao L; Pitisci A; De Mattia F; Brigida I; Algeri M; Montanari M; Palumbo G; Merli P; Rossi P; Aiuti A; Locatelli F; Bernardo ME Sci Rep; 2017 Aug; 7(1):8153. PubMed ID: 28811575 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells. Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911 [TBL] [Abstract][Full Text] [Related]
19. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy. Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow mesenchymal stem cells in patients with beta thalassemia major: molecular analysis with attenuated total reflection-Fourier transform infrared spectroscopy study as a novel method. Aksoy C; Guliyev A; Kilic E; Uckan D; Severcan F Stem Cells Dev; 2012 Jul; 21(11):2000-11. PubMed ID: 22214206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]